The capacity for complex tissue regeneration is unevenly distributed among vertebrate tissues and species. Salamanders and zebrafish possess remarkable potential to regenerate tissues like amputated appendages, resected heart muscle, and transected spinal cords 1,2 . Investigations of gene expression and function have generated molecular models for regeneration in multiple contexts, yet there is a gap to be filled in our understanding of the regulatory events that activate tissue regeneration programs [1] [2] [3] [4] [5] . Recent genome-wide chromatin analyses suggest that gene regulatory elements comprise a substantial portion of genomic sequence. Of these elements, distal-acting regulatory sequences, or enhancers, represent the most abundant class 6, 7 . Enhancers can direct expression of their target genes and have been predominantly examined as a means for stage-and tissue-specific regulation during embryonic development 8, 9 . Studies have also implicated enhancers in disease and as targets during evolution [10] [11] [12] [13] [14] [15] . Such findings raise the possibility that enhancer elements may also exist that engage with transcription factors in response to tissue damage to regulate genetic programs for regeneration. The identification of such elements could potentially inspire new solutions for manipulating regenerative events.
leptin b induction during fin and heart regeneration
To identify genes that are induced during tissue regeneration, we collected RNA from uninjured and regenerating tissues of adult zebrafish and sequenced transcriptomes. Our analyses identified 2,408 genes with significantly higher expression in tail fins at 4 days post-amputation (dpa), and 859 genes with significantly higher expression in cardiac ventricles 7 days after induced genetic ablation of half of all cardiomyocytes (Extended Data Fig. 1a and Supplementary Tables 1  and 2 ). In total, 360 genes were induced twofold or greater in both tissues compared to uninjured tissues (Extended Data Fig. 1a ). Among these genes, 69 were present at low levels in uninjured fins and highly induced during regeneration (Supplementary Information). The gene leptin b (lepb), one of two zebrafish paralogues related to mammalian leptin, a secreted regulator of energy homeostasis 16 , had the highest relative change during fin regeneration of genes in this group (130-fold; Fig. 1b-d) . Upon local injury of the cardiac ventricle by partial resection, lepb expression was induced in the endocardium, the endothelial lining of inner myofibres that has been implicated in regenerative events (Extended Data Fig. 1b , c, e) 17, 18 . To capture the regulatory elements responsible for lepb induction, we replaced the first exon of lepb with an eGFP reporter transgene within a 150 kb BAC containing 105 kb of DNA sequence upstream of the start codon (Fig. 1d ). Transgenic lepb:eGFP larvae had little or no detectable eGFP as viewed under a stereofluorescence microscope, and no fluorescence was detectable in fins or hearts throughout life ( Fig. 1e and Extended Data Fig. 1h , i, l, m). Upon fin amputation, lepb:eGFP fluorescence was sharply induced in regenerating structures, where fluorescence localized to blastemal mesenchyme ( Fig. 1e and Extended Data Fig. 1j, k) . lepb:eGFP was also induced in wounds of resected ventricles, as well as in atrial tissue distant from the site of injury (Fig. 1g) , a signature observed with other injury-induced markers 17, 18 . While sparse lepb:eGFP could be detected in epicardial tissue at 1 day post-resection (dpa; data not shown), cardiac lepb:eGFP fluorescence was predominantly endocardial by 3 dpa (Fig. 1g, h ). Thus, sequences within a ~150 kb genomic region surrounding lepb direct regeneration-dependent expression in fin and cardiac tissues.
lepb-linked enhancer directs expression after injury
Enhancers are identifiable as areas of open chromatin, bound by transcription factors and occupied by histones possessing various modifications, such as acetylated lysine 27 of histone H3 (H3K27ac) 19, 20 . To define areas of open chromatin, we assayed genomic regions surrounding lepb for H3K27ac marks by ChIP-seq in samples of uninjured and regenerating hearts. Two regions within the lepb BAC, located 7 kb and 3 kb upstream of the lepb start codon, displayed enrichment with H3K27ac marks in regenerating, but not uninjured, samples ( Fig. 2a and Extended Data Fig. 3a, b) . To examine if either of these distal How tissue regeneration programs are triggered by injury has received limited research attention. Here we investigate the existence of enhancer regulatory elements that are activated in regenerating tissue. Transcriptomic analyses reveal that leptin b (lepb) is highly induced in regenerating hearts and fins of zebrafish. Epigenetic profiling identified a short DNA sequence element upstream and distal to lepb that acquires open chromatin marks during regeneration and enables injury-dependent expression from minimal promoters. This element could activate expression in injured neonatal mouse tissues and was divisible into tissue-specific modules sufficient for expression in regenerating zebrafish fins or hearts. Simple enhancer-effector transgenes employing lepb-linked sequences upstream of pro-or anti-regenerative factors controlled the efficacy of regeneration in zebrafish. Our findings provide evidence for 'tissue regeneration enhancer elements' (TREEs) that trigger gene expression in injury sites and can be engineered to modulate the regenerative potential of vertebrate organs.
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regions exhibited enhancer activity, we established several transgenic lines containing 2 kb, 6 kb, and 7 kb upstream sequences of lepb fused to an eGFP reporter gene (referred to hereafter as P2:eGFP, P6:eGFP, and P7:eGFP) ( Fig. 2b and Extended Data Fig. 3c ). Upon fin amputation, only P7:eGFP animals, with regulatory sequences encompassing the distal H3K27ac-rich area in the transgene, displayed strong blastemal expression that was comparable to lepb:eGFP BAC transgenic animals ( Fig. 2c and Extended Data Fig. 3d ; P6:eGFP fins showed expression below the amputation site). Similarly, whereas P2:eGFP and P6:eGFP animals occasionally displayed induced fluorescence in myocardium and epicardium after cardiac injury, only injured P7:eGFP hearts displayed strong endocardial fluorescence ( Fig. 2c and Extended Data Fig. 3f ). Thus, a short DNA element located 7 kb upstream of the lepb coding sequence is important for directing gene expression in regenerating adult tissues.
We next examined whether an isolated 1.3 kb sequence that corresponded to the H3K27ac-rich region could activate gene expression when fused to P2, the presumed lepb promoter (Fig. 2b and Extended Data Fig. 3c ). Although reporter eGFP fluorescence was not evident in uninjured adult fins or hearts of transgenic fish containing this lepb-linked distal element, fin amputation and ventricular resection activated eGFP fluorescence in blastemal and endocardial cells, respectively, in a similar manner to the lepb BAC sequences ( Fig. 2c and Extended Data Fig. 3d-f) . From a genome-wide H3K27ac survey, we also identified many 1-2 kb intergenic regions at other genomic loci that acquired H3K27ac marks during regeneration. We assessed sequence conservation and examined potential enhancer activity by transient transgenic reporter assays using several regions, some of which enabled expression from a minimal lepb promoter after injury (Extended Data Fig. 4a-d and Supplementary Information).
To further validate the lepb-linked element, we examined its ability to influence the cell type-specific promoters cmlc2 (cardiomyocytes) and α-cry (lens) in stable transgenic reporter lines. Robust, regenerationdependent eGFP fluorescence was evident in fins and hearts of transgenic animals harbouring either the cmlc2 or α-cry promoters (Extended Data Figs 5 and 9a, b, d, g ). Thus, a small intergenic element we now refer to as lepb-linked enhancer, or LEN, can direct regenerationactivated gene expression from multiple promoters. Data Fig. 4e ). This sequence divergence likely reflects rapid evolution of enhancers, reported in previous studies 21, 22 . To examine whether zebrafish LEN has activity in mammalian injury contexts, we fused it upstream of a construct containing a murine minimal hsp68 promoter and a lacZ reporter gene. We generated two stable lines, one of which displayed vascular endothelial X-gal staining in uninjured neonatal hearts and paws (Extended Data Fig. 6b ). A second line had a small number of X-gal-positive cells in uninjured neonatal tissues and was selected for injury studies (LEN-hsp68::lacZ) (Fig. 3a, b) . Neonatal digit tips amputated at P2 phalanges do not regenerate lost structures effectively 23 , whereas injured neonatal ventricles display a regenerative response 24 . Strikingly, amputated digit tips and damaged ventricles of all injured postnatal day 1 LEN-hsp68::lacZ neonates showed conspicuous X-gal staining in wounds 3 days after surgeries. A control transgenic line with an unrelated enhancer fragment also exhibited low basal expression in uninjured neonatal tissues, but unlike LEN-hsp68::lacZ animals, showed no detectable activation of the lacZ reporter upon injury to the digits or ventricle (Fig. 3a, b and Extended Data Fig. 6a ). While future tests of LEN activity using a panel of promoters and transgene integration sites will be important, overall, these results suggest that zebrafish LEN sequences can interact with mammalian transcriptional machinery to enable injuryinduced expression in mice.
LEN-associated expression in injured mouse tissues

LEN is separable into tissue-specific modules
To identify minimal sequences responsible for the activity of LEN, we tested the ability of various fragments to direct regeneration-activated expression. We found that more distal LEN fragments composed of approximate nucleotides 1-850, 450-1000, 450-850 or 660-850 could each drive eGFP expression from the lepb 2 kb promoter during fin regeneration ( Fig. 9c, h ). Thus, our analyses suggested the presence of two separate, tissue-specific enhancer modules (Fig. 4c) .
We analysed sequences of the minimal 190 nucleotide (nt) (fin) and 316 nt (heart) elements, and identified distinct sets of predicted transcription factor binding motifs. LEN(663-854) contains predicted AP-1, Sox, forkhead, and ETS binding sites, and we confirmed by transgenic reporter assays that a predicted AP-1 binding site at LEN(776-782) is necessary to direct expression in regenerating fins (Extended Data Fig. 9i, j) . LEN(1034-1350) contains predicted NFAT, GATA, forkhead, and ETS binding sites, motifs associated with expression in endothelial cells 25, 26 (Extended Data Fig. 9i ). In total, our findings indicate a composite arrangement of regulatory elements with distinct tissue preferences within the LEN regeneration enhancer.
LEN element constructs control regenerative capacity
Recent studies have described new enhancer-target gene pairings caused by chromosomal rearrangements that underlie genetic diseases like cancer and neurological disorders 10, 12, 15 . To examine a parallel idea for experimentally guiding tissue regeneration, we designed transgenic constructs positioning LEN and the minimal lepb promoter upstream of pro-or anti-regenerative factors. A possible outcome is that LEN would limit embryonic expression of potent developmental influences to permit maturation from the one-cell stage to adulthood, but also trigger and sustain expression of these influences upon tissue damage.
To create enhancer-effector transgenes, we took advantage of the dependency of fin regeneration on signalling by fibroblast growth factors (Fgfs) 4, 27 . We first positioned LEN upstream of a cDNA encoding a dominant-negative form of fgfr1 (dnfgfr1)-a potent inhibitor of embryonic development 27,28 -and injected this construct into wild-type embryos. We established stable lines of zebrafish harbouring either P2:dnfgfr1 or LENP2:dnfgfr1, demonstrating that dnfgfr1 expression was limited to developmentally insignificant levels. Adult P2:dnfgfr1 fins displayed no detectable dnfgfr1 induction after amputation and regenerated normally. By contrast, injury to LENP2:dnfgfr1 animals induced strong expression of dnfgfr1 (detectable by dnfgfr1-eGFP fusion protein fluorescence) that was restricted to the amputation plane. Moreover, these animals displayed conspicuous defects or outright failures in fin regeneration (Fig. 5a, b) . In some cases, fin rays failed to regenerate even by 30 dpa and maintained dnfgfr1 expression Figure 5 | LEN controls fin regeneration when paired with Fgf effectors. a, Quantification of third and fourth ray lengths from each lobe at 3 and 5 dpa. *P < 0.01, one-way ANOVA; n = 40 (10), 56 (14), and 40 (10) for wild-type, P2:dnfgfr1, and LENP2:dnfgfr1 fin rays (number of animals indicated within the brackets), respectively. b, Representative images of 5 dpa fin regenerates that were used for quantification of regenerate lengths in a. Bottom, inset indicates dnfgfr1-eGFP fluorescence from boxed area. c, Images of 30 dpa LENP2:dnfgfr1 fin regenerate. eGFP fluorescence from boxed areas (left and right, with high-magnification images below), maintained in impaired rays (right). d, Section ISH for fgf20a expression (arrows) in wild-type, dob; LENP2:fgf20a, dob, and dob; P2:fgf20a fin regenerates at 3 dpa. e, 3 dpa fin regenerates from animals in d, stained for EdU incorporation (green) and nuclei (DAPI, blue), indicating extensive blastemal proliferation (arrows) in wild-type and dob; LENP2:fgf20a regenerates. Fins were collected 60 min after EdU injection. f, Quantification of third and fourth ray lengths from each lobe at 5 and 10 dpa. *P < 0.01, one-way ANOVA; n = 100 (25), 72 (18), 56 (14), and 100 (25) for wild-type, dob; LENP2:fgf20a, dob, and dob; P2:fgf20a fin rays (animals) at 5 dpa, respectively; n = 98 (25), 72 (18), 56 (14), and 96 (24) at 10 dpa, respectively. g, Representative images of 5 dpa fin regenerates that were used for quantification of regenerate lengths in f. The LENP2:fgf20a transgene rescues fin regeneration in dob animals, shown with controls at 5 dpa. Arrowheads in b-e, g, amputation planes. Scale bars represent 500 μm (b, c, g); 20 μm (d, e).
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in ray stumps, indicating persistent activation of LEN in the setting of regenerative failure (Fig. 5c and Extended Data Fig. 10b) .
We complemented these experiments with a gain-of-function approach, based on the discovery that mutations in the fgf20a ligand gene, devoid of blastema (dob), arrest fin regeneration 4 . We positioned LEN and the minimal lepb promoter upstream of a fgf20a cDNA and injected this construct into one-cell dob embryos. We generated stable lines of control dob; P2:fgf20a and dob; LENP2:fgf20a animals, indicating that these constructs restricted ectopic fgf20a expression during embryonic development. Upon amputation of adult tail fins, dob; P2:fgf20a animals induced no additional detectable fgf20a and displayed regenerative blocks comparable to dob animals (Fig. 5d, f, g ). By contrast, LENP2 sequences directed broad expression of fgf20a in mesenchymal cells upon fin amputation (Fig. 5d, f, g ). Remarkably, blastemal cell proliferation was stimulated in amputated dob; LENP2:fgf20a fins, and these animals regenerated patterned structures that were often of normal length (Fig. 5e-g ). In some cases, the lobed pattern of the tail fin was restored, and in no cases were there uncontrolled growth phenotypes (Fig. 5g) .
Targeted cardiomyocyte proliferation by LEN
Heart regeneration occurs through injury-induced stimulation of proliferation by pre-existing cardiomyocytes 29 . Recent evidence indicates that the secreted factor neuregulin1 (Nrg1) is a cardiomyocyte mitogen during cardiac growth or repair in lower and higher vertebrates [30] [31] [32] . In zebrafish, nrg1 is present at very low levels in the heart, and it is induced upon injury at levels that remain undetectable by standard ISH methodology 31 . Strong transgenic overexpression of nrg1 in adult zebrafish cardiomyocytes activates overt cardiomyocyte proliferation and enlarges the ventricular wall 31 . To test whether LEN can influence heart regeneration, we created stable transgenic zebrafish lines with P2:nrg1 or LENP2:nrg1 constructs. Resection of the ventricular apex sharply increased nrg1 transcripts in injured portions of LENP2:nrg1, but not control P2:nrg1, ventricles (Fig. 6a, b) . LENinduced nrg1 expression was strongest in 7 dpa injury sites, slightly less prominent at 14 dpa, and scarcely detectable by 30 dpa, typically when a contiguous muscle wall has regenerated (Fig. 6a) . To examine effects of targeted nrg1 enhancement, we quantified cardiomyocyte proliferation indices in LENP2:nrg1 and P2:nrg1 ventricles at 14 dpa. LENP2:nrg1 injury sites had a 52% increase in cardiomyocyte proliferation compared to P2:nrg1 wounds, indicative of improved muscle regeneration (Fig. 6c, d) . By 30 dpa, when nrg1 levels approached baseline, regenerated ventricular walls appeared grossly normal (Fig. 6a) . Thus, LEN can be designed to deliver mitogenic factors preferentially to areas of cardiac damage, boosting injury-induced cardiomyocyte proliferation.
Discussion
Here, we used a profiling approach to identify small regulatory elements that direct gene expression in regenerating tissue, which we have termed tissue regeneration enhancer elements (TREEs). Recently, a ~18 kb region of the murine Bmp5 locus was reported to activate expression from minimal promoters in injury contexts 33 , suggesting it may harbour a TREE analogous to the LEN element we describe here. We suspect that diverse classes of TREEs exist, including elements activated during development and re-activated by injury 34 or during regeneration, elements that activate expression preferentially during regeneration in multiple tissues, and regeneration-specific elements that are more tissue-restricted. The investigation of individual binding motifs within TREEs should identify upstream transcriptional regulators of regeneration, whereas genomic TREE locations can pinpoint novel downstream target genes.
Current methodologies to interrogate regenerative biology often have experimental disadvantages like multiple transgenes, ubiquitous promoters, irreversible expression, and/or stressful stimuli like oestrogen analogues, tetracycline analogues or heat shock 35 . By contrast, TREEs are single-transgene systems that can naturally induce and maintain target genes upon injury, and then naturally temper expression as regeneration concludes. Whereas LEN elements induce expression in fin mesenchyme and/or endocardium, we expect that future investigations will uncover a panel of regeneration-responsive TREEs representing additional distinct tissues. Thus, when combined 
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with effectors or genome-editing enzymes, TREEs should facilitate targeted genetic manipulations that have been elusive to this point.
Multiple features of TREEs are appealing with respect to the design of potential regenerative therapies. Previous studies have implicated the manipulation of enhancer activity as a means to treat human genetic disease 12, 36 . In this study, we report that pro-or anti-regenerative factors directed by TREEs are capable of blocking regenerative growth, promoting cell proliferation, or even rescuing genetic defects in regeneration. With a TREE-based system, factor delivery is spatiotemporally defined and could permit therapeutic cycles as injury recurs. Notably, although Nrg1 impacts heart regeneration, systemic neuregulin delivery has the potential for neurological or oncogenic effects 37, 38 . Thus, enhancer-based targeting of Nrg1 to injury sites, as we model here in zebrafish, may represent a more effective regenerative medicine platform. We suggest that TREEs identified from natural regenerative contexts across vertebrate species can inform new strategies for precise factor delivery to injured human tissues.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Information is available in the online version of the paper.
METHODS
Zebrafish maintenance and procedures. Wild-type or transgenic male and female zebrafish of the outbred Ekkwill (EK) strain were used for all experiments, with adults ranging in age from 3 to 12 months. Water temperature was maintained at 26°C for animals unless otherwise indicated. Fins were amputated to 50% of their original length using razor blades. As penetrance of the dob mutation was higher at 33°C than at 26°C, dob fish were maintained at 33°C after caudal fin amputation. To measure lengths of regenerates, lengths from the amputation plane to the distal tips of the third and fourth fin rays of dorsal and ventral caudal fin lobes were determined using ZEN software. Because some dob animals regenerated portions of the first and second fin rays of ventral lobes, regenerating caudal fin areas for Extended Data Fig. 10c were measured from the dorsal third fin ray to the ventral third fin ray and calculated using ZEN software. Partial ventricular resection surgeries were performed as described previously 39 , in which ~20% of the cardiac ventricle was removed at the apex. To ablate cardiomyocytes, cmlc2:CreER; bactin2:loxp-mCherry-STOP-loxp-DTA (Z-CAT) fish were used 40 . Z-CAT zebrafish were incubated in vehicle (0.01% EtOH) or 10 μM tamoxifen for 12 h. Work with zebrafish was performed in accordance with Duke University guidelines.
To generate lepb:eGFP BAC transgenic animals (full names, Tg(lepb:eGFP) pd120 and Tg(lepb:eGFP) pd121 ), the iTol2 cassette 41 was integrated into the BAC clone DKEY-21O22 using Red/ET recombineering technology (GeneBridges). Then, the first exon of the lepb gene in the BAC clone DKEY-21O22 was replaced with an eGFP cassette by Red/ET recombineering. 5′ and 3′ homology arms were amplified by PCR (Supplementary Information) and subcloned into the pCS2-eGFP plasmid. One nl of 50 ng μl −1 purified, recombined BAC was injected into one-cell stage zebrafish embryos along with one nl of 30 ng μl −1 synthetic Tol2 mRNA 41 . To sort F 0 transgenic animals injected with lepb:eGFP constructs, fin folds were amputated at 3 or 4 dpf, and embryos displaying eGFP fluorescence near the injury site at 1 dpa were selected (Extended Data Fig. 1f ). After raising F 0 zebrafish to adulthood, caudal fins were amputated and zebrafish displaying induced eGFP were selected for breeding (Extended Data Fig. 1g ). Between 30-60 dpf, caudal fins of progeny from transgene-positive F 0 fish were amputated, and eGFP + transgenic animals were isolated to identify stable lines. Two lines were identified that had indistinguishable expression features.
To define LEN activity, over 60 additional new transgenic lines were established in this study, listed in Supplementary Data 1. To generate transgenic animals, DNA sequences were amplified by PCR with indicated primers (Supplementary Data 3) and subcloned into a pCS2-eGFP-I-sceI vector, in which I-SceI restriction sites were flanked by a multiple cloning site. As promoters, 2 kb, 1.6 kb, and 0.7 kb upstream sequences of lepb, cmlc2 (ref. 42) , and α-cry 43 genes were used, respectively. These constructs were injected into one-cell-stage wild-type or dob embryos using standard meganuclease transgenesis techniques. 2 kb lepb upstream sequences could induce transgene expression after fin fold amputation at larval stages, but never after caudal fin amputation in adults. To isolate stable lines, larvae were examined for transgene expression near injury site in response to fin fold amputation (2 kb lepb), in cardiomyocytes (1.6 kb cmlc2), and in lens (0.7 kb α-cry).
To test additional TREEs, we subcloned putative enhancer regions of il11a, plek, vcana, and cd248b upstream of 800 bp of lepb upstream sequence (P0.8).
To define TREE activity, these constructs were injected into one-cell-stage wildtype embryos, Fin folds were amputated at 4 dpf, and eGFP fluorescence near the amputation plane was examined at 5 dpf (1 dpa). Generation and analysis of transgenic mice. Transgenic mice (CD-1 strain) were generated by oocyte microinjection as described previously 44 . LENhsp68::lacZ transgenic mice were generated by subcloning the zebrafish LEN enhancer sequence into the transgenic reporter plasmid hsp68-lacZ 45 . Ctrlhsp68::lacZ transgenic mice harbour a transgene, Prkaa2[mMEF2(1+2)] -hsp68-lacZ, which contains a modified version of a 931-bp enhancer sequence from the mouse Prkaa2 gene cloned into hsp68-lacZ (J. Hu and B. L. Black, unpublished observations). Partial apical resection injury in male and female neonatal mice at postnatal day 1 was performed similarly to previously described methods 46 . Hearts and paws were collected at postnatal day 4. All experiments with mice complied with federal and institutional guidelines and were reviewed and approved by the UCSF IACUC. RNA isolation and quantitative PCR. RNA was isolated from dissected caudal fins and partially resected ventricles using Tri-Reagent (Sigma). cDNA was synthesized from 1 μg of total RNA using the Roche First Strand Synthesis Kit. Quantitative PCR was performed using the Roche LightCycler 480 and the Roche LightCycler 480 Probes Master. All samples were analysed in biological triplicates and technical duplicates. Primer sequences are described in Supplementary Information, and probe numbers for actb2, lepb, and nrg1 were 104, 156 and 76, respectively. lepb and nrg1 transcript levels were normalized to actb2 levels for all experiments. RNA sequencing. Total RNA was prepared from two biological replicate pools of ablated Z-CAT ventricles and uninjured ventricles at 7 days post-ablation as per Gemberling et al.
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, or regenerating and uninjured caudal fins. Generation of mRNA libraries and sequencing were performed at the Duke Genome Sequencing Shared Resource using an Illumina HiSeq2000. Sequences were aligned to the zebrafish genome (Zv9) using TopHat 47 . Differentially regulated transcripts were identified using EdgeR and an FDR cut-off of 0.1 (ref. 48) . Accession numbers for transcriptome data sets are GSE75894 and GSE76564. ChIP sequencing. To identify candidate enhancer elements activated during heart regeneration, chromatin extracts were prepared from two biological replicate pools of 10 ablated Z-CAT ventricles and 10 uninjured ventricles. Chromatin was sonicated and immunoprecipitated with an antibody against H3K27ac (ActiveMotif) using the MAGnify ChIP system (Invitrogen). Sequencing libraries were prepared as per Bowman, et al. 49 . Sequencing was performed using an Illumina HiSeq2000, and 10-25 million 50 bp single end reads were obtained for each library. Sequences were aligned to the zebrafish genome (Zv9) using Bowtie2 (ref. 50) . Differential peaks were identified using Model-based Analysis for ChiP-seq (MACS) 51 . Histology and imaging. In situ hybridization on cryosections of 4% paraformaldehydefixed fins was performed as described previously 52 . To generate digoxigeninlabelled probes for lepb and fgf20a, we generated a fragment of lepb cDNA and a full length of fgf20a cDNA by PCR using primer sequences described in Supplementary Information. The nrg1 probe was prepared as described previously 31 . Immunohistochemistry was performed as described previously 40 . Primary and secondary antibodies used in this study were: anti-myosin heavy chain (mouse, F59, Developmental Studies Hybridoma Bank), anti-MEF2 (rabbit, sc-313, Santa Cruz Biotechnology), anti-PCNA (mouse, P8825, Sigma), antieGFP (rabbit, A11122, Life Technologies), anti-eGFP (chicken, GFP-1020, Aves Labs), anti-Raldh2 (rabbit, Abmart), anti-Ds-Red (rabbit, 632496, Clontech), anti-p63 (mouse, 4A4, Santa Cruz Biotechnology), Alexa Fluor 488 (mouse and rabbit; Life Technologies), Alexa Fluor 594 (mouse and rabbit; Life Technologies). For EdU incorporation experiments, zebrafish were injected intraperitoneally with 10 mM EdU (A10055, sigma), and caudal fins were collected at 1 h post-treatment. EdU staining was performed as previously described 53 . The secondary antibody used for EdU staining was Alexa 488 azide (10-20 μM, Sigma). Whole-mount images were acquired using an M205FA stereofluorescence microscope (Leica) or Axio Zoom (Zeiss). Images of tissue sections (10 μm for hearts and 14 μm for fins) were acquired using an LSM 700 confocal microscope (Zeiss). X-gal staining to detect β-galactosidase activity and counterstaining with nuclear fast red were performed with murine tissue as described previously 44 . Data collection and statistics. Clutchmates were randomized into different treatment groups for each experiment. No animal or sample was excluded from the analysis unless the animal died during the procedure. Sample sizes were chosen on the basis of previous publications and experiment types, and are indicated in each figure legend or methods. No statistical methods were used to predetermine sample size. For expression patterns, at least five fish from each transgenic line were examined. At least 9 hearts of each group were pooled for RNA purification and subsequent RT-qPCR. Quantification of cardiomyocyte proliferation and calculation of statistical outcomes were assessed by a person blinded to the treatments. Other experiments were not blinded during experiments and outcome assessment. Sample sizes, statistical tests, and P values are indicated in the figures or the legends. One-way ANOVA tests were applied when normality and equal variance tests were passed. The Mann-Whitney rank sum test was applied in assays of cardiomyocyte proliferation.
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Extended Data Figure 1 | lepb transcripts sharply increase during fin and heart regeneration. a, Venn diagram displaying numbers of genes with significantly increased transcript levels during fin and heart regeneration. b, RT-PCR of samples from 2 days post-fertilization (dpf) and 4 dpf embryos, and uninjured and regenerating adult tissues. lepb was not detected during embryogenesis and in uninjured tissues, but induced during regeneration. β-act2 is used as loading control. Uninj, Uninjured. c, Left: relative expression of lepb in uninjured, 1, 2, and 4 dpa fin regenerates. lepb transcript levels are increased at 1 and 2 dpa. Right: relative expression of lepb in uninjured or 3 dpa cardiac ventricles, assessed by qPCR. d, e, Endogenous lepb expression assessed by in situ hybridization in sections of fins (d) and cardiac ventricle and atrium (e). Arrowhead, amputation plane. Arrows, endocardial lepb expression. Left: uninjured tissues, Right: regenerating tissues. dpa: days post-amputation. f, g, F 0 animals, injected with the transgenic lepb:eGFP BAC reporter construct at the one-cell stage, induced eGFP after larval fin fold amputation (f) and during adult fin regeneration (g). Note that lepb:eGFP is mosaically expressed. Arrowheads, amputation planes. h, i, Expression pattern of lepb:eGFP stable transgenic animals. lepb:eGFP was not detected in fin and heart during embryogenesis (2 dpf (h); 4 dpf (i)). Below 'i' are enlargements of the boxed areas, which show heart (left) and fin fold (right). Dotted line, outline of fin fold. The yolk is autofluorescent. j, k, Section images of lepb:eGFP caudal fin regenerates at 2 dpa (j) and 4 dpa (k). The majority of lepb:eGFP-positive cells are mesenchymal cells, overlapping partially with cells that incorporate EdU (collected 60 min after injection; red). l, m, Lack of detectable expression of lepb:eGFP in hearts of uninjured (l) or sham-operated (m) lepb:eGFP animals. n = 8 and 5 for uninjured and sham-operated hearts, respectively. Arrowheads, amputation planes. Scale bars represent 10 μm (d, f, h-k); 50 μm (e, l, m) ; 500 μm (g). Information) . n = 7 and 6 for uninjured and 3 dpa hearts, respectively. f-j, Analysis of fin and heart regeneration in lepb pd94 mutants. f, A schematic representation of Lepb, showing the effects of the pd94 mutation. Lepb is composed of 5 alpha-helix domains. lepb pd94 has a 19 bp insertion and a 3 bp deletion at the third α-helix (helix C). g, Sequencing of wild-type and lepb pd94 alleles revealed an indel (red highlight). h, A comparison of the amino acid sequences of leptin genes of human, mice, and zebrafish. The predicted amino acid sequence of the lepb pd94 gene product is shown at the bottom, with the predicted truncation sites indicated in red. The predicted lepb pd94 protein product lacks the majority of C-terminal amino acids. Asterisk indicates identical amino acid residue between three species. i, Quantification of regenerated fin lengths from lepb pd94 and wild type siblings at 4 dpa. n = 12 each of lepb pd94 and wild-type. j, Quantification of cardiomyocyte proliferation at 7 dpa. n = 7 (lepb pd94 ) and 8 (wild-type). Data are represented as mean ± s.e.m. NS, not significant.
